Domestic Generic Drug Fast-Track Review Program aims to expedite approval for drugs made from domestic materials.
Author: PharmaSignal News Desk
Amgen Repatha pricing sees a 60% reduction in the U.S. through a new program, enhancing market access.
Generic mifepristone approval by FDA expands access to abortion care, offering a new option for patients.
EU pharmaceutical policy overhaul aims to improve access to medicines, impacting millions across Europe.
Chiesi Arbor partnership focuses on advancing gene editing therapies for rare diseases, targeting primary hyperoxaluria type 1.
Pharma companies are seeking agreements with Trump following Pfizer’s deal, aiming to lower drug prices.
Algen AstraZeneca partnership aims to enhance AI-driven drug discovery, focusing on chronic inflammatory conditions for innovative solutions.
Galapagos cell therapy sale decision expected soon as company reviews limited proposals from financial investors.
Keytruda subcutaneous launch by Merck aims to offset sales decline as original loses patent protection, with analysts projecting market impact.
Ascletis weight loss drug ASC47 shows over 56% greater body weight reduction when combined with semaglutide in obesity treatment.